Last edition
News about "LMICs"
Valneva and Serum Institute End Chikungunya Vaccine Licensing Deal
Valneva SE and the Serum Institute of India have mutually agreed to discontinue their licensing agreement for Valneva’s single-shot chikungunya vaccine, bringing the collaboration to a close by mutual consent.
LMICs | 01/01/2026 | By News Bureau
Biocon Biologics' Report Offers Insights on Increasing Biosimilars Adoption in LMICs
Biocon Biologics commissioned the study, defined the methodology and collaborated with Clarivate to develop the final report.
LMICs | 09/10/2024 | By Aishwarya | 454
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy